A Randomized, Double-blind, Placebo-controlled, Paralles

  • Schulz, S. Charles (PI)

Project: Research project

Project Details

Description

A Randomized, Double-blind, Placebo-controlled, Paralles, 26-Week, Phase 3 study of 2 Doses of an Alpha-7Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or
StatusFinished
Effective start/end date10/1/139/30/15

Funding

  • ENVIVO PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.